Door to balloon time in primary percutaneous coronary intervention in ST elevation myocardial infarction: every minute counts
- PMID: 35880558
- DOI: 10.1097/MCA.0000000000001145
Door to balloon time in primary percutaneous coronary intervention in ST elevation myocardial infarction: every minute counts
Abstract
Objectives: This study examines relationships between door to balloon (D2B) time and subsequent admissions due to heart failure (HF), acute coronary syndrome (ACS), and mortality for up to 1 year.
Background: Current guidelines set 90-min for D2B time for primary percutaneous coronary intervention (PPCI) as a goal, which has been shown to reduce mortality and adverse events.
Methods: Using the MDclone ADAMS system integrated with our electronic medical records, we conducted retrospective analysis of all patients admitted due to ST-elevation myocardial infarction from home, without any history of HF or coronary disease, and who underwent PPCI during 2013-2019. Data on D2B time, baseline clinical and demographic characteristics, and outcomes of HF, ACS and mortality were collected. Adjusted HR for each of the outcomes was calculated by multivariate Cox model.
Results: A total of 826 patients were included in the final analysis. D2B had no significant effect on incidence of heart failure admissions for up to 1-year follow-up. D2B had a significant effect on mortality at 180 days, showing a 30% increase for each 30-min increase (HR 1.308; CI, 1.046-1.635) as for ACS at 90 days (HR 1.307; 1.025-1.638). The 30-min D2B cutoff showed a significant increase in ACS recurrence throughout the follow-up period at 90 days (HR 2.871, 1.239-6.648), 180 days (HR 2.607, 1.255-5.413), and 1 year (HR 1.886, 1.073-3.317).
Conclusions: Patients with shorter D2B times had significantly reduced mortality and recurrence of ACS, with no effect on heart failure admission incidence.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Similar articles
-
Prognostic Implications of Door-to-Balloon Time and Onset-to-Door Time on Mortality in Patients With ST -Segment-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.J Am Heart Assoc. 2019 May 7;8(9):e012188. doi: 10.1161/JAHA.119.012188. J Am Heart Assoc. 2019. PMID: 31041869 Free PMC article.
-
Direct Admission of Patients With ST-Segment-Elevation Myocardial Infarction to the Catheterization Laboratory Shortens Pain-to-Balloon and Door-to-Balloon Time Intervals but Only the Pain-to-Balloon Interval Impacts Short- and Long-Term Mortality.J Am Heart Assoc. 2021 Jan 5;10(1):e018343. doi: 10.1161/JAHA.120.018343. Epub 2020 Dec 21. J Am Heart Assoc. 2021. PMID: 33345559 Free PMC article.
-
Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study.Lancet. 2015 Mar 21;385(9973):1114-22. doi: 10.1016/S0140-6736(14)61932-2. Epub 2014 Nov 19. Lancet. 2015. PMID: 25467573 Free PMC article.
-
Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis.Heart. 2018 Aug;104(16):1362-1369. doi: 10.1136/heartjnl-2017-312517. Epub 2018 Feb 5. Heart. 2018. PMID: 29437704
-
The Effect of Sex on Door-to-Balloon Time in Patients Presenting With ST-Elevation Myocardial Infarction and Referred for Primary Percutaneous Coronary Intervention: A Systematic Review.Cardiovasc Revasc Med. 2022 Apr;37:120-127. doi: 10.1016/j.carrev.2021.07.011. Epub 2021 Jul 13. Cardiovasc Revasc Med. 2022. PMID: 34334335
Cited by
-
Analysis of the Weekend Effect on Mortality, Diagnostic Coronary Angiography, and Percutaneous Coronary Intervention in Acute Myocardial Infarction Across Rural US Hospitals.Cureus. 2024 Feb 7;16(2):e53751. doi: 10.7759/cureus.53751. eCollection 2024 Feb. Cureus. 2024. PMID: 38465191 Free PMC article.
References
-
- The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993; 329:1615–1622.
-
- Brodie BR, Stone GW, Cox DA, Stuckey TD, Turco M, Tcheng JE, et al. Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial. Am Heart J. 2006; 151:1231–1238.
-
- Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2016; 133:1135–1147.
-
- Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med. 2017; 376:2053–2064.
-
- Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000;283:2941–2947.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous